Skip to main content

Table 1 Demographics of study participants

From: Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A

Trial registration number

NCT00427830

NCT00456183

NCT00460590

NCT00480558

Country

UK

UK

South Africa

South Africa

No of participants

11

11

10

12

LTBI

-

+

-

+

History of BCG

+

+/−

+/−

+/−

Dose of MVA85A

5 × 107 PFU

5 × 107 PFU

5 × 107 PFU

5 × 107 PFU

Age, median (range)

27 (21–54)

30.5 (20–49)

35.5 (20.7–48.7)

36 (27–49)

Gender, % male

39

83

33.3

75

serum samples available, week (number)

0 (10), 1 (5), 4 (8)

0 (10), 1 (6), 4 (10)

0 (10), 1 (10)

-

PBMC samples available, week (number)

0 (8), 1 (9), 4 (9)

-

-

-